MedPath

Hypofractionated intensity-modulated radiation therapy for prostate cancer

Not Applicable
Conditions
Prostate cancer
Registration Number
JPRN-UMIN000022951
Lead Sponsor
Department of Radiation Oncology, Graduate School of Medical and Dental Sciences, Niigata University
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
Male
Target Recruitment
39
Inclusion Criteria

Not provided

Exclusion Criteria

1) Patients who received radiotherapy for prostate. 2) Patients who received surgery for prostate. 3) Patients with uncontrolled active infection. 4) Cancer patients with a duplication of activity. 5) Patients with serious complications (uncontrollable collagen disease, heart disease, pulmonary disease, liver disease). 6) Mental diseases which prevent from registration of this trial. 7) Patients who received chemotherapy for prostate cancer. 8) Patients with inflammatory bowel disease. 9) Patients with severe or uncontrollable diabetes mellitus. 10) Risk organs are too close to the PTV to keep dose constraints. 11) Patients judged inappropriate for this study by the physicians.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath